AVTX- Avalo Therapeutics, Inc.

Name: Avalo Therapeutics, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Avalo Therapeutics, Inc. (AVTX) has 9 insiders with recent SEC Form 4 filings, including 132 buys and 0 sells. AVTX is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
Other	Boyd Taylor	275.0K	$4.04M	-
Other	Doyle Mittie	47.8K	$702.7K	-679
CFO	Sullivan Christopher Ryan	19.1K	$281.0K	-
Other	Varki Paul	3.6K	$53.4K	-
Dir	Chan Mitchell	3.2K	$46.5K	-

Activity

Buys and sells only

Transactions

10 filings · page 10

Date	Insider	Role	Type	Shares	Price	Value	Chg%
Dec 10, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	36,400	$3.41	$124,145.63	-
Dec 4, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	25,797	$3.49	$90,153.37	-
Nov 29, 2018	Armistice Capital, LLC56	10% Owner	Buy	77,803	$3.51	$272,863.77	-
Nov 26, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	50,000	$3.59	$179,407.00	-
Nov 20, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	49,100	$3.61	$177,292.62	-
Nov 15, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	31,314	$3.85	$120,577.82	-
Oct 31, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	5,986	$3.92	$23,481.35	-
Oct 29, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	107,800	$3.95	$425,512.48	-
Oct 24, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	125,800	$4.13	$519,064.36	-
Oct 9, 2018	Armistice Capital, LLC56	Director, 10% Owner	Buy	29,600	$4.34	$128,404.61	-

← PrevPage 10Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC